Previous Article | Next Article 
Mol Cell Biol, July 1998, p. 3744-3751, Vol. 18, No. 7
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cyclosporin A-Sensitive Transcription Factor
Egr-3 Regulates Fas Ligand Expression
Paul R.
Mittelstadt and
Jonathan D.
Ashwell*
Laboratory of Immune Cell Biology, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland
20892-1152
Received 3 February 1998/Returned for modification 16 March
1998/Accepted 3 April 1998
Activation-induced transcriptional upregulation of the ligand for
Fas (FasL) and the resulting apoptosis of Fas-bearing cells constitute
essential steps in a host of normal and pathological processes. Here we
describe an activation-inducible cis-acting regulatory
element in the fasL promoter that is required for gene expression. Oligonucleotide competition and antibody supershift analyses identified two activation-induced DNA-binding species: Egr-1
(NGFI-A, krox-24, zif268, TIS-8), a transcription factor that has been
implicated in growth, differentiation, and apoptosis; and Egr-3
(PILOT), a transcription factor of no previously known function.
Activation-induced expression of Egr-3, like that of FasL, was
inhibited by cyclosporin A, whereas expression of Egr-1 was unaffected.
Transient expression of Egr-3 alone increased fasL promoter
activity in a cyclosporin A-insensitive manner, whereas expression of
Egr-1 had little effect. Moreover, endogenous fasL mRNA was
induced in nonlymphoid cells by forced expression of Egr-3 in the
absence of any other stimulus. These studies identify a critical Egr
family-binding site in the fasL promoter and demonstrate that activation-induced Egr-3, but not Egr-1, directly upregulates fasL transcription in response to activating stimuli.
*
Corresponding author. Mailing address: Laboratory of
Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bldg. 10, Room 1B-40, Bethesda, MD 20892-1152. Phone: (301)
496-4931. Fax: (301) 402-4844. E-mail:
jda{at}Box-j.nih.gov.
Mol Cell Biol, July 1998, p. 3744-3751, Vol. 18, No. 7
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tan, N. Y., Li, J.-M., Stocker, R., Khachigian, L. M.
(2009). Angiotensin II-Inducible Smooth Muscle Cell Apoptosis Involves the Angiotensin II Type 2 Receptor, GATA-6 Activation, and FasL-Fas Engagement. Circ. Res.
105: 422-430
[Abstract]
[Full Text]
-
Iannello, A., Samarani, S., Debbeche, O., Ahmad, R., Boulassel, M.-R., Tremblay, C., Toma, E., Routy, J.-P., Ahmad, A.
(2009). Potential Role of Interleukin-18 in the Immunopathogenesis of AIDS: Involvement in Fratricidal Killing of NK Cells. J. Virol.
83: 5999-6010
[Abstract]
[Full Text]
-
Fionda, C., Nappi, F., Piccoli, M., Frati, L., Santoni, A., Cippitelli, M.
(2007). 15-Deoxy-{Delta}12,14-Prostaglandin J2 Negatively Regulates rankl Gene Expression in Activated T Lymphocytes: Role of NF-{kappa}B and Early Growth Response Transcription Factors. J. Immunol.
178: 4039-4050
[Abstract]
[Full Text]
-
Manicassamy, S., Sun, Z.
(2007). The Critical Role of Protein Kinase C-{theta} in Fas/Fas Ligand-Mediated Apoptosis. J. Immunol.
178: 312-319
[Abstract]
[Full Text]
-
Collins, S., Wolfraim, L. A., Drake, C. G., Horton, M. R., Powell, J. D.
(2006). Cutting Edge: TCR-Induced NAB2 Enhances T Cell Function by Coactivating IL-2 Transcription. J. Immunol.
177: 8301-8305
[Abstract]
[Full Text]
-
Castellano, R., Vire, B., Pion, M., Quivy, V., Olive, D., Hirsch, I., Van Lint, C., Collette, Y.
(2006). Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling: ROLE OF DNA METHYLATION AND PROTEIN ACETYLATION SUGGEST DISTINCT MECHANISMS OF TRANSCRIPTIONAL REPRESSION. J. Biol. Chem.
281: 14719-14728
[Abstract]
[Full Text]
-
Cippitelli, M., Fionda, C., Di Bona, D., Piccoli, M., Frati, L., Santoni, A.
(2005). Hyperthermia Enhances CD95-Ligand Gene Expression in T Lymphocytes. J. Immunol.
174: 223-232
[Abstract]
[Full Text]
-
Xiao, S., Deshmukh, U. S., Jodo, S., Koike, T., Sharma, R., Furusaki, A., Sung, S.-s. J., Ju, S.-T.
(2004). Novel Negative Regulator of Expression in Fas Ligand (CD178) Cytoplasmic Tail: Evidence for Translational Regulation and against Fas Ligand Retention in Secretory Lysosomes. J. Immunol.
173: 5095-5102
[Abstract]
[Full Text]
-
Torgler, R., Jakob, S., Ontsouka, E., Nachbur, U., Mueller, C., Green, D. R., Brunner, T.
(2004). Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex. J. Biol. Chem.
279: 37334-37342
[Abstract]
[Full Text]
-
Yasunaga, J.-i., Taniguchi, Y., Nosaka, K., Yoshida, M., Satou, Y., Sakai, T., Mitsuya, H., Matsuoka, M.
(2004). Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia. Cancer Res.
64: 6002-6009
[Abstract]
[Full Text]
-
Yoo, Y.-G., Lee, M.-O.
(2004). Hepatitis B Virus X Protein Induces Expression of Fas Ligand Gene through Enhancing Transcriptional Activity of Early Growth Response Factor. J. Biol. Chem.
279: 36242-36249
[Abstract]
[Full Text]
-
Xi, H., Kersh, G. J.
(2004). Sustained Early Growth Response Gene 3 Expression Inhibits the Survival of CD4/CD8 Double-Positive Thymocytes. J. Immunol.
173: 340-348
[Abstract]
[Full Text]
-
Xi, H., Kersh, G. J.
(2004). Early Growth Response Gene 3 Regulates Thymocyte Proliferation during the Transition from CD4-CD8- to CD4+CD8+1. J. Immunol.
172: 964-971
[Abstract]
[Full Text]
-
Pardo, J., Buferne, M., Martinez-Lorenzo, M.-J., Naval, J., Schmitt-Verhulst, A.-M., Boyer, C., Anel, A.
(2003). Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression. Int Immunol
15: 1441-1450
[Abstract]
[Full Text]
-
Droin, N. M., Pinkoski, M. J., Dejardin, E., Green, D. R.
(2003). Egr Family Members Regulate Nonlymphoid Expression of Fas Ligand, TRAIL, and Tumor Necrosis Factor during Immune Responses. Mol. Cell. Biol.
23: 7638-7647
[Abstract]
[Full Text]
-
Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., Tonegawa, S.
(2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. USA
100: 8993-8998
[Abstract]
[Full Text]
-
Cippitelli, M., Fionda, C., Di Bona, D., Lupo, A., Piccoli, M., Frati, L., Santoni, A.
(2003). The Cyclopentenone-Type Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanisms. J. Immunol.
170: 4578-4592
[Abstract]
[Full Text]
-
Wu, J., Metz, C., Xu, X., Abe, R., Gibson, A. W., Edberg, J. C., Cooke, J., Xie, F., Cooper, G. S., Kimberly, R. P.
(2003). A Novel Polymorphic CAAT/Enhancer-Binding Protein {beta} Element in the FasL Gene Promoter Alters Fas Ligand Expression: A Candidate Background Gene in African American Systemic Lupus Erythematosus Patients. J. Immunol.
170: 132-138
[Abstract]
[Full Text]
-
Chaudhry, S., Freebern, W. J., Smith, J. L., Butscher, W. G., Haggerty, C. M., Gardner, K.
(2002). Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene. J. Immunol.
169: 6767-6778
[Abstract]
[Full Text]
-
Kavurma, M. M., Bobryshev, Y., Khachigian, L. M.
(2002). Ets-1 Positively Regulates Fas Ligand Transcription via Cooperative Interactions with Sp1. J. Biol. Chem.
277: 36244-36252
[Abstract]
[Full Text]
-
Li, L., Qi, X., Williams, M., Shi, Y., Keegan, A. D.
(2002). Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death. J. Immunol.
168: 6215-6223
[Abstract]
[Full Text]
-
Yang, Y., Dong, B., Mittelstadt, P. R., Xiao, H., Ashwell, J. D.
(2002). HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter. J. Biol. Chem.
277: 19482-19487
[Abstract]
[Full Text]
-
Ise, W., Totsuka, M., Sogawa, Y., Ametani, A., Hachimura, S., Sato, T., Kumagai, Y., Habu, S., Kaminogawa, S.
(2002). Naive CD4+ T Cells Exhibit Distinct Expression Patterns of Cytokines and Cell Surface Molecules on Their Primary Responses to Varying Doses of Antigen. J. Immunol.
168: 3242-3250
[Abstract]
[Full Text]
-
Miller, A. T., Berg, L. J.
(2002). Defective Fas Ligand Expression and Activation-Induced Cell Death in the Absence of IL-2-Inducible T Cell Kinase. J. Immunol.
168: 2163-2172
[Abstract]
[Full Text]
-
Cippitelli, M., Fionda, C., Di Bona, D., Di Rosa, F., Lupo, A., Piccoli, M., Frati, L., Santoni, A.
(2002). Negative Regulation of CD95 Ligand Gene Expression by Vitamin D3 in T Lymphocytes. J. Immunol.
168: 1154-1166
[Abstract]
[Full Text]
-
Kirchhoff, S., Sebens, T., Baumann, S., Krueger, A., Zawatzky, R., Li-Weber, M., Meinl, E., Neipel, F., Fleckenstein, B., Krammer, P. H.
(2002). Viral IFN-Regulatory Factors Inhibit Activation-Induced Cell Death Via Two Positive Regulatory IFN-Regulatory Factor 1-Dependent Domains in the CD95 Ligand Promoter. J. Immunol.
168: 1226-1234
[Abstract]
[Full Text]
-
Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L., Williams, M. S.
(2002). Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation: Selective Regulation of Mitogen-Activated Protein Kinase Activation and Fas Ligand Expression. JEM
195: 59-70
[Abstract]
[Full Text]
-
Wasem, C., Frutschi, C., Arnold, D., Vallan, C., Lin, T., Green, D. R., Mueller, C., Brunner, T.
(2001). Accumulation and Activation-Induced Release of Preformed Fas (CD95) Ligand During the Pathogenesis of Experimental Graft-Versus-Host Disease. J. Immunol.
167: 2936-2941
[Abstract]
[Full Text]
-
Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., Riccardi, C.
(2001). Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor {kappa}B. Blood
98: 743-753
[Abstract]
[Full Text]
-
Roger, J., Chalifour, A., Lemieux, S., Duplay, P.
(2001). Cutting Edge: Ly49A Inhibits TCR/CD3-Induced Apoptosis and IL-2 Secretion. J. Immunol.
167: 6-10
[Abstract]
[Full Text]
-
Steff, A.-M., Trop, S., Maira, M., Drouin, J., Hugo, P.
(2001). Opposite Ability of Pre-TCR and {{alpha}}{{beta}}TCR to Induce Apoptosis. J. Immunol.
166: 5044-5050
[Abstract]
[Full Text]
-
Dzialo-Hatton, R., Milbrandt, J., Hockett, R. D. Jr., Weaver, C. T.
(2001). Differential Expression of Fas Ligand in Th1 and Th2 Cells Is Regulated by Early Growth Response Gene and NF-AT Family Members. J. Immunol.
166: 4534-4542
[Abstract]
[Full Text]
-
Lindgren, H., Axcrona, K., Leanderson, T.
(2001). Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2. J. Immunol.
166: 4578-4585
[Abstract]
[Full Text]
-
Gourley, T. S., Chang, C.-H.
(2001). Cutting Edge: The Class II Transactivator Prevents Activation-Induced Cell Death by Inhibiting Fas Ligand Gene Expression. J. Immunol.
166: 2917-2921
[Abstract]
[Full Text]
-
Wang, R., Zhang, L., Zhang, X., Moreno, J., Luo, X., Tondravi, M., Shi, Y.
(2001). Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-{{kappa}}B Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-{{alpha}} During T Cell Activation. J. Immunol.
166: 1983-1990
[Abstract]
[Full Text]
-
Delgado, M., Ganea, D.
(2001). Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-{{kappa}}B, NF-AT, and Early Growth Factors 2/3. J. Immunol.
166: 1028-1040
[Abstract]
[Full Text]
-
Norian, L. A., Latinis, K. M., Eliason, S. L., Lyson, K., Yang, C., Ratliff, T., Koretzky, G. A.
(2000). The Regulation of CD95 (Fas) Ligand Expression in Primary T Cells: Induction of Promoter Activation in CD95LP-Luc Transgenic Mice. J. Immunol.
164: 4471-4480
[Abstract]
[Full Text]
-
Chow, W. A., Fang, J. J., Yee, J.-K.
(2000). The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells. J. Immunol.
164: 3512-3518
[Abstract]
[Full Text]
-
Sevetson, B. R., Svaren, J., Milbrandt, J.
(2000). A Novel Activation Function for NAB Proteins in EGR-dependent Transcription of the Luteinizing Hormone beta Gene. J. Biol. Chem.
275: 9749-9757
[Abstract]
[Full Text]
-
Zhang, J., Gao, J.-X., Salojin, K., Shao, Q., Grattan, M., Meagher, C., Laird, D. W., Delovitch, T. L.
(2000). Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase. JEM
191: 1017-1030
[Abstract]
[Full Text]
-
Matsui, K., Xiao, S., Fine, A., Ju, S.-T.
(2000). Role of Activator Protein-1 in TCR-Mediated Regulation of the Murine fasl Promoter. J. Immunol.
164: 3002-3008
[Abstract]
[Full Text]
-
Aoudjit, F., Vuori, K.
(2000). Engagement of the alpha 2beta 1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner. Blood
95: 2044-2051
[Abstract]
[Full Text]
-
Li, X. R., Chong, A. S.-F., Wu, J., Roebuck, K. A., Kumar, A., Parrillo, J. E., Rapp, U. R., Kimberly, R. P., Williams, J. W., Xu, X.
(1999). Transcriptional Regulation of Fas Gene Expression by GA-binding Protein and AP-1 in T Cell Antigen Receptor{middle dot}CD3 Complex-stimulated T Cells. J. Biol. Chem.
274: 35203-35210
[Abstract]
[Full Text]
-
Zhang, J., Ma, B., Marshak-Rothstein, A., Fine, A.
(1999). Characterization of a Novel Cis-element That Regulates Fas Ligand Expression in Corneal Endothelial Cells. J. Biol. Chem.
274: 26537-26542
[Abstract]
[Full Text]
-
Milner, J. D., Kent, S. C., Ashley, T. A., Wilson, S. B., Strominger, J. L., Hafler, D. A.
(1999). Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone. J. Immunol.
163: 2522-2529
[Abstract]
[Full Text]
-
Pratt, J. C., van den Brink, M. R. M., Igras, V. E., Walk, S. F., Ravichandran, K. S., Burakoff, S. J.
(1999). Requirement for Shc in TCR-Mediated Activation of a T Cell Hybridoma. J. Immunol.
163: 2586-2591
[Abstract]
[Full Text]
-
O'Donovan, K. J., Baraban, J. M.
(1999). Major Egr3 Isoforms Are Generated via Alternate Translation Start Sites and Differ in Their Abilities To Activate Transcription. Mol. Cell. Biol.
19: 4711-4718
[Abstract]
[Full Text]
-
Ivanov, V. N., Ronai, Z.'e.
(1999). Down-regulation of Tumor Necrosis Factor alpha Expression by Activating Transcription Factor 2 Increases UVC-induced Apoptosis of Late-stage Melanoma Cells. J. Biol. Chem.
274: 14079-14089
[Abstract]
[Full Text]
-
Mittelstadt, P. R., Ashwell, J. D.
(1999). Role of Egr-2 in Up-regulation of Fas Ligand in Normal T Cells and Aberrant Double-negative lpr and gld T Cells. J. Biol. Chem.
274: 3222-3227
[Abstract]
[Full Text]
-
Mittelstadt, P. R., Ashwell, J. D.
(2001). Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ. J. Biol. Chem.
276: 29603-29610
[Abstract]
[Full Text]